SEC Form 4 · accession 0001615763-17-000003
Jazz Pharmaceuticals plc · JAZZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul Treacy
Officer — SVP, Technical Operations
Period of report
Aug 14, 2017
Accepted (ET)
Aug 15, 2017 · 4:59 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001232524
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF2 | Aug 14, 2017 | S | 200 | $143.406 | D | 17,489 | D | |
| Ordinary Shares | Aug 14, 2017 | S | 1,104 | $143.30 | D | 16,385 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
- F2Includes 110 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on May 31, 2017.